Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer

NCT01598792 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped Patient 2 suffered DLT post-vaccination. The vaccine manufacturers withdrew support for the study on commercial grounds.

Conditions

Interventions

Sponsor

University of Liverpool

Collaborators